Novartis Profit Tops Estimates as Cancer Drug Sales Offset Entresto Decline

Novartis AG reported higher-than-expected profit last quarter, according to Bloomberg, as newer cancer medicines helped offset declining sales of its aging blockbuster Entresto to generic rivals.